Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention?
暂无分享,去创建一个
E W Steyerberg | J Deinum | J. Habbema | E. Steyerberg | P. Krijnen | J. Deinum | P Krijnen | J D F Habbema | B C van Jaarsveld | B. V. Jaarsveld | J. Habbema
[1] P. Krijnen,et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] G. Bobrie,et al. Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate? , 2001, Journal of the American Society of Nephrology : JASN.
[3] W. Mali,et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. , 2001, Journal of the American Society of Nephrology : JASN.
[4] P. Krijnen,et al. Prospective studies of diagnosis and intervention: the Dutch experience. , 2000, Seminars in nephrology.
[5] S. Textor,et al. Ischemic nephropathy/azotemic renovascular disease. , 2000, Seminars in nephrology.
[6] S. Textor. Epidemiology and clinical presentation. , 2000, Seminars in nephrology.
[7] T. Pickering,et al. Renal vascular disease: medical management, angioplasty, and stenting. , 2000, Seminars in nephrology.
[8] A. Taylor. Functional testing: ACEI renography. , 2000, Seminars in nephrology.
[9] C. Wilcox. Functional testing: renin studies. , 2000, Seminars in nephrology.
[10] S. Textor,et al. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. , 2000, Mayo Clinic proceedings.
[11] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[12] C. Isles,et al. Management of renovascular disease: a review of renal artery stenting in ten studies. , 1999, QJM : monthly journal of the Association of Physicians.
[13] W. Mali,et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial , 1999, The Lancet.
[14] N. Polissar,et al. Prospective study of atherosclerotic disease progression in the renal artery. , 1998, Circulation.
[15] P. Krijnen,et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data. , 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[16] J. Webster,et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis , 1998, Journal of Human Hypertension.
[17] Pierre-François Plouin,et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. , 1998, Hypertension.
[18] K. Mclaughlin. Effect of renal-artery stenting on progression of renovascular renal failure , 1997, The Lancet.
[19] J. Seeger,et al. Prediction of Cure of Hypertension in Atherosclerotic Renal Artery Stenosis , 1996, Southern medical journal.
[20] B. Hendry,et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. , 1994, QJM : monthly journal of the Association of Physicians.
[21] Jeffrey Rimmer,et al. Atherosclerotic Renovascular Disease and Progressive Renal Failure , 1993, Annals of Internal Medicine.
[22] T. Sos. Angioplasty for the Treatment of Azotemia and Renovascular Hypertension in Atherosclerotic Renal Artery Disease , 1991, Circulation.
[23] M Fukunami,et al. Detection of Patients at Risk for Paroxysmal Atrial Fibrillation During Sinus Rhythm by P Wave‐Triggered Signal‐Averaged Electrocardiogram , 1991, Circulation.
[24] P. Waller,et al. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. , 1990, BMJ.
[25] T. Pickering. Renovascular hypertension: etiology and pathophysiology. , 1989, Seminars in nuclear medicine.
[26] S. Pocock,et al. Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.
[27] J. Laragh,et al. The captopril test for identifying renovascular disease in hypertensive patients. , 1986, The American journal of medicine.
[28] A. Ruol,et al. [Reno-vascular hypertension]. , 1968, Minerva medica.
[29] C. Wilcox,et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. , 2003, Kidney international.
[30] Anna Oliveras,et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] J. Olin,et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. , 2000, The New England journal of medicine.
[32] A. Novick. Renal Vascular Disease , 1996 .
[33] S. Senn,et al. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. , 1994, Statistics in medicine.
[34] M. Weinberger,et al. Renal vascular hypertension. Surgery vs. dilation. , 1986, Nephron.
[35] M. Weinberger,et al. Renal Vascular Hypertension , 1986 .
[36] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .